Cellectis Ownership | Who Owns Cellectis?
Cellectis Ownership Summary
Cellectis is owned by 13.59% institutional investors, 3.86% insiders, and 82.56% retail investors. Long focus capital management is the largest institutional shareholder, holding 4.61% of CLLS shares. American Funds SMALLCAP World A is the top mutual fund, with 1.85% of its assets in Cellectis shares.
CLLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cellectis | 13.59% | 3.86% | 82.56% |
| Sector | Healthcare Stocks | 76.79% | 9.87% | 13.34% |
| Industry | Biotech Stocks | 60.64% | 9.74% | 29.62% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Long focus capital management | 4.62M | 4.61% | $8.31M |
| Ubs asset management americas | 1.44M | 1.44% | $2.59M |
| Millennium management | 534.55K | 0.53% | $962.19K |
| Baillie gifford | 290.43K | 0.29% | $522.77K |
| Ubs group | 229.08K | 0.23% | $412.35K |
| Macquarie group | 226.88K | 0.23% | $408.00K |
| Lpl financial | 91.79K | 0.13% | $171.64K |
| Morgan stanley | 86.33K | 0.12% | $161.43K |
| First affirmative financial network | 25.86K | 0.03% | $46.55K |
| Wells fargo & company/mn | 24.59K | 0.02% | $44.26K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Long focus capital management | 4.62M | 0.27% | $8.31M |
| First affirmative financial network | 25.86K | 0.03% | $46.55K |
| Pom investment strategies | 495.00 | 0.00% | $891.00 |
| Ubs asset management americas | 1.44M | 0.00% | $2.59M |
| Macquarie group | 226.88K | 0.00% | $408.00K |
| Millennium management | 534.55K | 0.00% | $962.19K |
| Baillie gifford | 290.43K | 0.00% | $522.77K |
| Harbour investments | 4.50K | 0.00% | $8.10K |
| Acadian asset management | 19.92K | 0.00% | $34.00K |
| Lpl financial | 91.79K | 0.00% | $171.64K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 534.55K | 0.00% | 534.55K |
| Ubs group | 229.08K | 0.00% | 229.08K |
| Acadian asset management | 19.92K | 0.00% | 19.92K |
| Wells fargo & company/mn | 24.59K | - | 12.50K |
| Lpl financial | 91.79K | 0.00% | 10.44K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -1.85M |
| Principal financial group | - | - | -411.80K |
| Baillie gifford | 290.43K | 0.00% | -403.51K |
| Kbc group nv | - | - | -163.45K |
| Oppenheimer | - | - | -133.89K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Millennium management | 534.55K | 0.00% | 534.55K | $962.19K |
| Ubs group | 229.08K | 0.00% | 229.08K | $412.35K |
| Acadian asset management | 19.92K | 0.00% | 19.92K | $34.00K |
| Principal securities | 52.00 | - | 52.00 | $94.00 |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -1.00 |
| Toronto dominion bank | -31.00 |
| Frg family wealth advisors | -80.00 |
| Qube research | -112.00 |
| Old point trust & financial services n a | -250.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 27 | -12.90% | 13,602,212 | 6.61% | 13 | 8.36% | 9 | -25.00% | 8 | 33.33% |
| Dec 31, 2024 | 20 | -31.03% | 5,664,103 | -42.00% | 5 | 5.94% | 8 | 33.33% | 5 | -28.57% |
| Sep 30, 2024 | 29 | -3.33% | 9,766,379 | -0.06% | 9 | 5.27% | 6 | -25.00% | 7 | - |
| Jun 30, 2024 | 30 | -6.25% | 9,772,626 | -0.83% | 13 | 4.33% | 8 | -33.33% | 7 | 40.00% |
| Mar 31, 2024 | 32 | -8.57% | 9,854,602 | 0.39% | 17 | 5.68% | 12 | -14.29% | 5 | -28.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 1.85M | 1.85% | - |
| UBS Lux Dgtl Hlth Eq Fd seeding P acc | 1.44M | 1.44% | - |
| UBS (Lux) Digital Health Equity SB USD | 1.44M | 1.44% | - |
| Principal U.S. Small Cap Equity | 289.60K | 0.29% | -4.40K |
| Delaware Healthcare I | 226.88K | 0.23% | - |
| Macquarie Healthcare I | 226.88K | 0.23% | - |
| Galileo - Biotech Innovation Fund S USD | 226.07K | 0.23% | - |
| Principal SmallCap R5 | 199.15K | 0.20% | -90.45K |
| Baillie Gifford Global Discovery A Acc | 147.53K | 0.15% | -1.93K |
| Vanguard International Explorer Inv | 122.03K | 0.12% | - |
CLLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools